Relevant bibliographies by topics / AIDS (Disease) Treatment Victoria

Academic literature on the topic 'AIDS (Disease) Treatment Victoria'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'AIDS (Disease) Treatment Victoria.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "AIDS (Disease) Treatment Victoria"

1

Sileo, K. M., R. K. Wanyenze, W. Kizito, E. Reed, S. K. Brodine, H. Chemusto, W. Musoke, B. Mukasa, and S. M. Kiene. "Multi-level Determinants of Clinic Attendance and Antiretroviral Treatment Adherence Among Fishermen Living with HIV/AIDS in Communities on Lake Victoria, Uganda." AIDS and Behavior 23, no. 2 (June 29, 2018): 406–17. http://dx.doi.org/10.1007/s10461-018-2207-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cooper, R. G., and P. D. Reid. "Sexually transmitted disease/HIV health-care policy and service provision in Britain." International Journal of STD & AIDS 18, no. 10 (October 1, 2007): 655–61. http://dx.doi.org/10.1258/095646207782193777.

Full text
Abstract:
The objective of this paper was to discusses historical developments of sexually transmitted disease (STD)/HIV sexual health policies in Britain, principally from the 19th to the 21st century. Repeating trends were identified and a consideration of how history addresses today's urgent need for better management of sexual health is discussed. In January 1747, the first venereal disease (VD) treatment was established at Lock Hospital, London. As the 19th century passed, sexuality emerged from a conspiracy of silence and became part of social consciousness. In Victorian times, prostitution was regarded with revulsion. Renewed medical interest in VD was brought about by improvements in medical knowledge from 1900–10. In the period 1913–17, there was a significant change in sexual health policy. From 1918, treatment centres increasingly recognized the difficulties in persuading attendees to return for a complete course of treatment. AIDS in Britain wrecked havoc in the period 1981–86 with incidences of infection in several widely differing groups and public alarm fuelled by the media. In conclusion, education, advertising and public health counselling need to be moulded effectively so that the public recognize the real risks associated with unprotected sexual intercourse.
APA, Harvard, Vancouver, ISO, and other styles
3

Guy, Rebecca J., Ann M. McDonald, Mark J. Bartlett, Jo C. Murray, Carolien M. Giele, Therese M. Davey, Ranil D. Appuhamy, et al. "Characteristics of HIV diagnoses in Australia, 1993-2006." Sexual Health 5, no. 2 (2008): 91. http://dx.doi.org/10.1071/sh07070.

Full text
Abstract:
Objective: To describe recent trends in the diagnosis of HIV infection in Australia. Methods: National HIV surveillance data from 1993 to 2006 were analysed with a focus on geographic differences by HIV exposure route and late presentation (HIV within 3 months of a first AIDS-defining illness or a CD4 count of less than 200 cells μL–1). Results: In 1993–99, the number of HIV diagnoses declined by 32%, and then increased by 39% from 1999 to 2006. From 2000 onwards, rates increased significantly in Victoria, Queensland, South Australia and Western Australia. The most frequently reported routes of HIV exposure were male to male sex (71%) and heterosexual contact (18%), and the population rate of diagnoses have increased in both categories. Among the cases reported as heterosexually acquired (n = 2199), 33% were in people born in a high-prevalence country and 19% in those with partners from a high-prevalence country. Late presentation was most frequent in heterosexually acquired infections in persons who had a partner from a high-prevalence country: 32% compared with 20% overall. Conclusions: Recent increases in annual numbers of HIV diagnoses in Australia underline the continuing need for HIV-prevention programs, particularly among men having male to male sex. Early diagnosis and access to care and treatment should also be emphasised, as a substantial proportion of people with HIV infection are unaware of their status until late in the course of disease.
APA, Harvard, Vancouver, ISO, and other styles
4

Thomas, S. L., K. Lam, L. Piterman, A. Mijch, and P. A. Komesaroff. "Complementary medicine use among people living with HIV/AIDS in Victoria, Australia: practices, attitudes and perceptions." International Journal of STD & AIDS 18, no. 7 (July 1, 2007): 453–57. http://dx.doi.org/10.1258/095646207781147292.

Full text
Abstract:
There is limited evidence suggesting the underlying reasons for the use of complementary and alternative medicines (CAMs) by people with HIV/AIDS, or individual attitudes and beliefs about the use of CAMs. Using focus groups and a survey with 151 individuals attending the HIV Clinics at The Alfred Hospital, Melbourne, we aimed to provide insights into factors that influence the use of CAMs among people living with HIV/AIDS. Roughly half (49%) of the participants had used CAMs to manage their HIV/AIDs. Users of CAMs utilized a wide range of treatments in managing their condition, but costs of the CAMs meant that users were not necessarily able to use them as much as they might have liked. Use of CAMs was based on a desire to find something beneficial rather than on being dissatisfied with conventional medicine. Further research is needed into (a) the effects of CAMs and (b) the enhancement of communication and collaboration between patients, doctors and complementary medicine practitioners.
APA, Harvard, Vancouver, ISO, and other styles
5

Kinney, Evlin L., Jean-Jacques Monsuez, Michel Kitzis, and Daniel Vittecoq. "Treatment of AIDS-Associated Heart Disease." Angiology 40, no. 11 (November 1989): 970–76. http://dx.doi.org/10.1177/000331978904001106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Philip Bill Okaka, Olan’g Alfred, Florence Ondieki - Mwaura, and Maurice Sakwa. "Effect of Community Health Support Systems and Technology Obsolescence on Utilization of mHealth Information by Teenagers Living with HIV/AIDS in Island Communities of Lake Victoria, Kenya." International Journal of World Policy and Development Studies, no. 73 (July 11, 2021): 45–56. http://dx.doi.org/10.32861/ijwpds.73.45.56.

Full text
Abstract:
The emergence of mHealth as an alternative access point for care and treatment is lauded by development agencies as ingenious innovation for bridging health care access for teenagers living with HIV/AIDS among detached communities like the islands of Lake Victoria. It is also presumed that mHealth transcends beyond teenagers’ concerns with location and unfriendly hours of operation of health facilities. mHealth is alleged to increase privacy and confidentiality, reduce the cost of service delivery, and loops over retrogressive cultural beliefs and attitudes exhibited by health care providers and caregivers, consequently increasing access to health information, care, and treatment. Specifically, the study sought to determine the technology obsolescence and explore community-based health support systems that facilitate suitable utilization of mHealth by teenagers living with HIV from the island communities of Lake Victoria and its effect on treatment access. To support this study, two philosophies: The theory of Reasoned Action and the Technology Adoption Lifecycle Model were applied. Anchored on cross-sectional study design, stratified sampling identified the psychosocial support groups of teenagers living with HIV. The probit model was applied to the study. With a study population of approximately 409 in Ringiti, Remba, Rusinga, Mfangano, and Mageta Islands, questionnaires were administered to 173 sampled teenagers living with HIV as a unit of analysis, and a control group made up of 30 percent of the sample ascertained effect of mHealth on treatment access. Five focus group discussions and key informant interviews of 10 and 3 were held on each Island. Multiple linear regression analysis was used to estimate the effect of the independent variables on the dependent variable. Further, the results showed that technology obsolescence and community-based health support systems had a significant effect on access to treatment by teenagers living with HIV/AIDS in the Island communities of Lake Victoria. Consequently, this study provides organizations promoting access to access to treatment by teenagers living with HIV/AIDS through mHealth. The study recommended that government and organizations involved in HIV/AIDS related activities should adopt a culture of enhancing mHealth by focusing on technology obsolescence and community-based health support systems. This could go a long way in ensuring there is improved access to treatment by teenagers living with HIV/AIDS in Island communities of Lake Victoria.
APA, Harvard, Vancouver, ISO, and other styles
7

Volberding, Paul. "Treatment of malignant disease in AIDS patients." AIDS 2 (1988): S169–176. http://dx.doi.org/10.1097/00002030-198800001-00025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Navarro, Willis H., and Lawrence D. Kaplan. "AIDS-related lymphoproliferative disease." Blood 107, no. 1 (January 1, 2006): 13–20. http://dx.doi.org/10.1182/blood-2004-11-4278.

Full text
Abstract:
Abstract Not long after the recognition of HIV as the causative agent of AIDS, it was evident that individuals infected with HIV developed lymphoma at a greater rate than the population at large. Approximately two thirds of AIDS-related lymphoma (ARL) cases are categorized as diffuse large B-cell type, with Burkitt lymphomas comprising 25% and other histologies a much smaller proportion. Typically, these individuals have presented with advanced extranodal disease and CD4+ lymphocyte counts of less than 200/mm3. Recent clinical trials have demonstrated a better outcome with chemotherapy for ARL since the introduction of combination antiretroviral treatment, termed highly active antiretroviral therapy (HAART). For patients with relapses, solid evidence points to the safety and utility of hematopoietic-cell transplantation as a salvage modality. Coinfection with other viruses such as Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus have led to the genesis of previously rare or unrecognized lymphoma subtypes such as plasmablastic and primary effusion lymphomas. The immunosuppressive impact of treatment for patients with ARL receiving chemotherapy with HAART appears transient and opportunistic infections have become less problematic than prior to HAART. Significant progress has been made in the understanding and management of ARL but outcomes still remain inferior compared to those achieved in HIV- individuals.
APA, Harvard, Vancouver, ISO, and other styles
9

Mönkemüller, Klaus E., and C. Mel Wilcox. "Diagnosis and Treatment of Colonic Disease in AIDS." Gastrointestinal Endoscopy Clinics of North America 8, no. 4 (October 1998): 889–911. http://dx.doi.org/10.1016/s1052-5157(18)30238-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lawrence, Janet S. St, and Michael R. Kauth. "AIDS phobia: Disease patterns and possibilities of treatment." Clinical Psychology Review 10, no. 5 (January 1990): 607–9. http://dx.doi.org/10.1016/0272-7358(90)90101-f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "AIDS (Disease) Treatment Victoria"

1

Hoffmann, Toinette. "The right of the HIV/AIDS patient to treatment." Thesis, University of Port Elizabeth, 2001. http://hdl.handle.net/10948/277.

Full text
Abstract:
The objective of this treatise is to establish whether a right to social security exists in South Africa, which would entitle HIV positive persons in South Africa citizens to medical care. A study was made of various articles in journals and on the Internet to determine the South African government's policy on a right to social security and to providing medical treatment. It was found that South Africa lacks an integrated, holistic approach to social security and does not guarantee the right to social security, merely the right to have access to social security. The same was found with the right to medical care. Although there seems to be a general right to medical care which extends to and includes HIV-positive patients, the state merely guarantees the right to apply for medical treatment but does not guarantee the granting thereof. It is submitted that the Department of Health's refusal to implement a vertical transmission prevention programme and the failure to offer treatment as an alternative, for whatever reason, is "penny wise and pound foolish". In the long run more money is spent dealing with pediatric AIDS. It was further found that although the government attempted to lay a groundwork with the formulation and acceptance of the national AIDS plan, the successful implementation thereof is seriously hindered due to the lack of inter- and intra-departmental collaboration, essential health services and funding.
APA, Harvard, Vancouver, ISO, and other styles
2

McKallip, Robert James. "The immunomodulatory properties of AZT used in the treatment of AIDS." Thesis, This resource online, 1994. http://scholar.lib.vt.edu/theses/available/etd-06102009-063223/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Makhubele, Jabulani Calvin. "The impact of culture on the prevention and treatment of HIV/AIDS amongst people in low-resourced areas :a social work perspective." Thesis, University of Limpopo, 2004. http://hdl.handle.net/10386/2027.

Full text
Abstract:
Thesis (M. A. (Social Work)) -- University of Limpopo, 2004.
The aim of this study was to explore the impact of culture on the prevention and reatment of HIV/AIDS amongst people in low-resourced areas like Malamulele. he study focused on the lifestyles, beliefs, attitudes and perceptions around ultural elements and practices, which might impact negatively on the prevention nd treatment of the HIV/AIDS epidemic. There were three groups of research espondents namely: learners from three high schools in Malamulele, some arents of the learners and the traditional/cultural leaders. The researcher ollected both qualitative and quantitative data. The data was gathered through he use of an interview schedule (questionnaire), focus group discussions and ound-table discussion sessions. The data was presented, analysed and nterpreted by means of tables and charts. t was found that people in low-resourced (rural) areas have little knowledge about HIV/AIDS, causes, symptoms and how the disease is transmitted. Despite the fact that awareness and educational campaigns and programmes are being rendered, people in low-resourced (rural) areas have little knowledge and needed skills about prevention and treatment of the pandemic. Polygamy and extra-marital relations by men is still highly valued and viewed at high esteem. Religious structures seem to be detached to the issue of HIV/AIDS as they mentioned that talking about HIV/AIDS is immoral and against their principles. The study also tried to explore the extent to which people in low-resourced areas view and use condoms as a protective means.
APA, Harvard, Vancouver, ISO, and other styles
4

Garanganga, Eunice. "Palliative care needs of children suffering from AIDS, Zimbabwe." Thesis, [S.l. : s.n.], 2009. http://dk.cput.ac.za/cgi/viewcontent.cgi?article=1030&context=td_cput.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rushing, R. Mark. "An outpatient facility for the treatment of HIV/AIDS." Thesis, Georgia Institute of Technology, 1998. http://hdl.handle.net/1853/23302.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Walker, Blain S. "The diagnosis and treatment of major depression in AIDS patients : effect of counselor experience and attitude toward people with AIDS." Virtual Press, 1999. http://liblink.bsu.edu/uhtbin/catkey/1137581.

Full text
Abstract:
This study was an investigation into the clinical judgments made by counseling psychologists when faced with a patient who had major depression and AIDS. Two hundred and eighty one counseling psychologists evaluated one of four vignettes depicting an individual with major depression. In three of the vignettes the individual also had AIDS but the vignette varied on how the virus was contracted (unprotected gay sex, IV drug abuse, hemophilia). In the fourth vignette (the control group) the individual did not have AIDS. Results of the study suggested, that the presence of AIDS overshadows the evaluation and treatment decisions made by counseling psychologists when their patient has major depression and AIDS. Three factors-counseling psychologists' general experience with people who have AIDS, their clinical experience with AIDS patients and how the AIDS virus was contracted-were investigated for possible moderating effects of the overshadowing bias. How the AIDS virus was contracted was used as an indirect measure of clinician attitude toward people with AIDS. Neither general or clinical experience with AIDS patients appeared to have an effect on the diagnostic or treatment decisions made by counseling psychologists when evaluating depressed patients with AIDS. As with experience, method of contracting the AIDS virus did not have a moderating effect on the overshadowing bias. Implications of these results for the evaluation and treatment of depression in AIDS patients, as well as future research are discussed.
Department of Counseling Psychology and Guidance Services
APA, Harvard, Vancouver, ISO, and other styles
7

Marais, Melanie. "A descriptive study to evaluate the effect of guidelines used by counsellors to improve adherence to antiretroviral therapy in the private sector." Thesis, University of the Western Cape, 2006. http://etd.uwc.ac.za/index.php?module=etd&amp.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nikisi, Joseph. "Access to antiretroviral treatment in the public sector, in Zambia /." Access to E-Thesis, 2005. http://upetd.up.ac.za/thesis/available/etd-04282009-163207/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Petoumenos, Kathy Public Health &amp Community Medicine Faculty of Medicine UNSW. "Treatment experience and HIV disease progression: findings from the Australian HIV observational database." Awarded by:University of New South Wales. School of Public Health and Community Medicine, 2006. http://handle.unsw.edu.au/1959.4/24937.

Full text
Abstract:
The Australian HIV Observational Database (AHOD) is a collaboration of hospitals, sexual health clinics and specialist general practices throughout Australia, established in April 1999. Core data variables collected include demographic data, immunological and virological markers, AIDS diagnosis, antiretroviral and prophylactic treatment and cause of death. The first electronic data transfer occurred in September 1999 followed by six monthly data transfers thereafter. All analyses included in this thesis are based on patients recruited to AHOD by March 2004. By March 2004, 2329 patients had been recruited to AHOD from 27 sites throughout Australia. Of these, 352 (15%) patients were recruited from non-metropolitan clinics. The majority of patients were male (94%), and infected with HIV through male homosexual contact (73%). Almost 90% of AHOD patients are antiretroviral treatment experience, and the majority of patients are receiving triple therapy as mandated by standard of care guidelines in Australia. Antiretroviral treatment use has changed in Australia reflecting changes in the availability of new treatment strategies and agents. The crude mortality rate was 1.58 per 100 person years, and of the 105 deaths, more than half died from HIV-unrelated deaths. The prevalence of HBV and HCV in AHOD was 4.8% and 10.9%, respectively. HIV disease progression in the era of highly active antiretroviral treatment (HAART) among AHOD patients is consistent with what has been reported in developed countries. Common factors associated with HIV disease progression were low CD4 cell count, high viral load and prior treatment with mono or double therapy at the time of commencing HAART. This was demonstrated in AHOD in terms of long-term CD4 cell response, the rate of changing combination antiretroviral therapy and factors predicting death. HBV and HCV coinfection is also relatively common in AHOD, similar to other developed country cohorts. Coinfection does not appear to be serious impediments to the treatment of HIV infected patients. However, HIV disease outcome following HAART does appear to be adversely affected by HIV/HCV coinfection but not in terms of HIV/HBV coinfection. Patients attending non-metropolitan sites were found to be similar to those attending metropolitan sites in terms of both immunological response and survival.
APA, Harvard, Vancouver, ISO, and other styles
10

Ejigu, Amsalework Ayele. "Mathematical modelling of HIV/AIDS transmission under treatment structured by age of infection." Thesis, Stellenbosch : University of Stellenbosch, 2011. http://hdl.handle.net/10019.1/6628.

Full text
Abstract:
Thesis (MSc (Mathematical Sciences))--University of Stellenbosch, 2011.
Includes bibliography.
ENGLISH ABSTRACT: This thesis takes into account the different levels of infectiousness of the human immunodeficiency virus (HIV) infected individuals throughout their period of infection. Infectiousness depends on the time since infection. It is high shortly after the infection occurs and then much lower for several years, and thereafter a higher plateau is reached before the acquired immunodeficiency syndrome (AIDS) phase sets in. In line with this, we formulated a mathematical model which is structured according to the age of infection. To understand the dynamics of the disease, we first discuss and analyse a simple model in which the age of infection is not considered, but progression of the HIV-AIDS transmission is taken into consideration by introducing three stages of infection. Analysis of these models tells us that the disease can be eradicated from the population only if on average one infected individual infects less than one person in his or her infectious period, otherwise the disease persists. To investigate the reduction of the number of infections caused by a single infectious individual to less than one, we introduce different treatment strategies for a model which depends on the age of infection, and we analyse it numerically. Current strategies amount to introducing treatment only at a late stage of infection when the infected individual has already lived through most of the infectious period. From our numerical results, this strategy does not result in eradication of the disease, even though it does reduce the burden for the individual. To eradicate the disease from the population, everyone would need to be HIV tested regularly and undergo immediate treatment if found positive.
AFRIKAANSE OPSOMMING: Hierdie tesis hou rekening met die verskillende aansteeklikheidsvlakke van die menslike immuniteitsgebreksvirus (MIV) deur besmette individue gedurende hulle aansteeklikheidstydperk. Die graad van aansteeklikheid hang af van die tydperk sedert infeksie. Dit is hoog kort nadat die infeksie plaasvind en daarna heelwat laer vir etlike jare, en dan volg n hoer plato voordat uiteindelik die Verworwe-Immuniteitsgebreksindroom (VIGS) fase intree. In ooreenstemming hiermee, formuleer ons n wiskundige model van MIV-VIGSoordrag met n struktureer waarin die tydperk sedert infeksie bevat is. Om die dinamika van die siekte te verstaan, bespreek en analiseer ons eers n eenvoudige model sonder inagneming van die tydperk sedert infeksie, terwyl die progressie van MIV-VIGS-oordrag egter wel in ag geneem word deur die beskouing van drie stadiums van infeksie. Analise van die modelle wys dat die siekte in die bevolking slegs uitgeroei kan word as elke besmette mens gemiddeld minder as een ander individu aansteek gedurende die tydperk waarin hy of sy self besmet is, anders sal die siekte voortduur. Vir die ondersoek oor hoe om die aantal infeksies per besmette individu tot onder die waarde van een te verlaag, beskou ons verskeie behandelingsstrategiee binne die model, wat afhang van die tydperk sedert infeksie, en ondersoek hulle numeries. Die huidige behandelingstrategiee kom neer op behandeling slegs gedurende die laat sta- dium van infeksie, wanneer die besmette individu reeds die grootste deel van die aansteeklikheidsperiode deurleef het. Ons numeriese resultate toon dat hierdie strategie nie lei tot uitroeiing van die siekte nie, alhoewel dit wel die las van die siekte vir die individu verminder. Om die siekte binne die bevolking uit te roei, sou elkeen gereeld vir MIV getoets moes word en indien positief gevind, dadelik met behandeling moes begin.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "AIDS (Disease) Treatment Victoria"

1

S, James John, and James John S. AIDS treatment news. Berkeley, Calif: Celestial Arts, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kane, Brigid M. HIV/AIDS treatment drugs. Edited by Triggle D. J. New York NY: Chelsea House, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kane, Brigid M. HIV/AIDS treatment drugs. New York, NY: Chelsea House, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Linda, Anderson. Progress on the treatment of AIDS. [Bethesda, Md.?]: National Cancer Institute, Office of Cancer Communications, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

M, Ismail S. Homoeopathy, an anti-aids treatment. New Delhi: Mittal Publications, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bordowitz, Gregg. Drive: The AIDS crisis is still beginning : a collection of essays, dialogues, and texts surrounding Gregg Bordowitz's films Fast trip, long drop, and Habit, and his exhibition Drive, held at the Museum of Contemporary Art, Chicago, April 6-July 7, 2003. Chicago, Ill: WhiteWalls Inc., 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Raphael, Dolin, Masur Henry, and Saag Michael S, eds. AIDS therapy. 2nd ed. New York: Churchill Livingstone, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

C, Boyce, Human Sciences Research Council. Social Aspects of HIV/AIDS and Health, and Human Sciences Research Council. Child, Youth and Family Development Research Programme, eds. Assessing the costs of a rural PMTCT pilot site in the Eastern Cape: Monitoring HIV/AIDS interventions. Cape Town, South Africa: HSRC Publishers, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Badgley, Laurence. Healing AIDS naturally. 2nd ed. Foster City, California: Human Energy Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Badgley, Laurence. Healing AIDS naturally. San Bruno, Calif: Human Energy Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "AIDS (Disease) Treatment Victoria"

1

Capeau, J., M. Caron, and F. Boccara. "Pathogenesis of Antiretroviral Treatment-Associated Metabolic Syndrome." In Cardiovascular Disease in AIDS, 33–53. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dittmer, Dirk P., and Blossom Damania. "KSHV-Associated Disease in the AIDS Patient." In Cancer Treatment and Research, 129–39. Boston, MA: Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-46816-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Boccara, F., C. Meuleman, S. Ederhy, S. Lang, S. Janower, A. Cohen, and F. Raoux. "Coronary Artery Disease in HIV-Infected Patients: ClinicalPresentation,Pathophysiology, Prognosis,Prevention,and Treatment." In Cardiovascular Disease in AIDS, 111–29. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Busch, Katie A., and Sarz Maxwell. "Somatic Treatment of Psychiatric Symptoms in HIV Disease." In Behavioral Aspects of AIDS, 267–78. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4757-9386-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miller, David. "Diagnosis and Treatment of Acute Psychological Problems Related to HIV Infection and Disease." In Behavioral Aspects of AIDS, 187–206. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4757-9386-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dittmer, Dirk P., and Blossom Damania. "Kaposi’s Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update." In Cancer Treatment and Research, 63–80. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-03502-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wilson, Anika. "“Nobody Fears Aids, Mphutsi is More Fire”: Disease Rumors in the Age of Aids Treatment." In Folklore, Gender, and Aids in Malawi, 91–118. New York: Palgrave Macmillan US, 2013. http://dx.doi.org/10.1057/9781137322456_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Nutrients and Treatment of Heart Disease in AIDS." In AIDS and Heart Disease, 214–22. CRC Press, 2004. http://dx.doi.org/10.3109/9780203021897-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bruce, R. Douglas, Frederick L. Altice, and Gerald Friedland. "HIV Disease Among Substance Users: Treatment Issues." In Global HIV/AIDS Medicine, 513–26. Elsevier, 2008. http://dx.doi.org/10.1016/b978-1-4160-2882-6.50048-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Chapter 18. HIV/AIDS Prevention and Treatment." In Disease Control Priorities in Developing Countries (2nd Edition), edited by Dean T. Jamison, Joel G. Breman, Anthony R. Measham, George Alleyne, Mariam Claeson, David B. Evans, Prabhat Jha, Anne Mills, and Philip Musgrove, 331–70. World Bank Publications, 2006. http://dx.doi.org/10.1596/978-0-8213-6179-5/chpt-18.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "AIDS (Disease) Treatment Victoria"

1

Lobis, Yusuf Bachtiyar, Bhisma Murti, and Hanung Prasetya. "Influences of Peer Support Group and Psychosocio- Economic Determinants on Treatment Compliance in Hiv/Aids Patients in Sragen, Central Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.59.

Full text
Abstract:
Background: Adherence to treatment is important to reduce viral replication, improve clinical and immunological conditions, reduce the risk of developing ARV resistance, and reduce the risk of HIV transmission. Peer support is suspected to be one of the factors driving drug intake adherence in patients with chronic disease. This study aimed to examine the influences of peer support and psychosocio-economic determinants on treatment compliance in HIV/AIDS patients. Subjects and Method: This was a case control design study conducted in Sragen, Central Java, Indonesia. A sample of 200 people with HIV/AIDS (PLWH) was selected by fixed disease sampling. The dependent variable was treatment compliance. The independent variables were knowledge toward HIV/AIDS, perceived benefit, perceived belief, perceived threat, perceived susceptibility, perceived seriousness, perceived barrier, attitude, indirect experience, family support, and peer support. The data were obtained from medical record and questionnaire. The data were analyzed by a multiple logistic regression run on Stata 13. Results: Treatment compliance increased with strong peer support (b= 1.34; 95% CI= 0.31 to 2.38; p= 0.011), strong family support (b= 1.09; 95% CI= 0.16 to 2.02; p= 0.021), knowledge toward HIV/AIDS (b= 1.65; 95% CI= 0.67 to 2.64; p= 0.001), high perceived benefit (b= 1.23; 95% CI= 0.28 to 2.18; p= 0.011), perceived belief (b= 2.05; 95% CI= 0.98 to 3.12; p<0.001), and high perceived threat (b= 1.22; 95% CI= 0.30 to 2.13; p= 0.009). Treatment compliance decreased with negative attitude (b= -2.47; 95% CI= -3.58 to -1.37; p <0.001), low perceived susceptibility (b= -1.26; 95% CI= -2.24 to – 0.27; p= 0.012), low perceived seriousness (b= -1.11; 95% CI= -2.06 to -0.16; p=0.021), high perceived barrier (b= -1.76; 95% CI= -2.81 to -0.70; p= 0.001), and indirect experience (b= -1.10; 95% CI= -2.05 to -0.14; p= 0.024). Conclusion: Treatment compliance increases with strong peer support, strong family support, high knowledge toward HIV/AIDS, high perceived benefit, perceived belief, and high perceived threat. Treatment compliances decrease with negative attitude, low perceived susceptibility, low perceived seriousness, high perceived barrier, and indirect experience. Keywords: HIV/AIDS, treatment compliance, peer support, psychosocial economy Correspondence: Yusuf Bachtiyar Lobis. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: bachtiyar03@gmail.com. Mobile: +628111388841. DOI: https://doi.org/10.26911/the7thicph.02.59
APA, Harvard, Vancouver, ISO, and other styles
2

Takahashi, Hoyu, Wataru Tatewaki, Reizo Nagayama, Masaharu Hanano, Shin-ichiro Takizawa, and Akira Shibata. "HEAT-TREATED FACTOR VIII CONCENTRATES IN VON WILLEBRAND'S DISEASE AND RELATED DISORDERS: STUDIES IN PLATELET-TYPE VON WILLEBRAND'S DISEASE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644118.

Full text
Abstract:
Cryoprecipitate has proved to correct the hemostatic defects in von Willebrand1s disease (vWd). However, recent studies have revealed that transmission of the AIDS retrovirus (HIV) occurs through exposure to blood products including cryoprecipitate. Treatment with heat-treated factor VIII concentrates may have certain advantages over treatment with non-heated products, if these preparations are efficacious in vWd and related disorders. We investigated the multimeric compositoin of von Willebrand factor (vWf), contents of vWf antigen (vWf:Ag) and ristocetin cofactor activity (RCof) in the heat-treated factor VIII concentrates and cryoprecipitate, and their capacity to directly induce aggregation of platelet-type (or pseudo-) vWd platelets in vitro. The vWf multimers were visualized by a newly developed, immuno-enzymatic staining of the gel, following a discontinuous SDS-agarose gel electrophoresis. The RCof/vWf:Ag ratio was around 1.0 in cryoprecipitate, and ranged from 0.19 to 0.96 in factor VIII concentrates. Among four commercially available concentrates studied, Haemate P contained the most high-molecular-weight multimers of vWf and the highest RCof relative to vWf:Ag, and induced the aggregation of platelet-type vWd platelets at the lowest concentration. When infused into a patient with platelet-type vWd, Haemate P (144 units vWf:Ag/kg body weight) shortened the prolonged bleeding time and caused spontaneous platelet aggregation in vitro with a mild diminution of platelet count (from the preinfusion value of 183,000μl to 139,000μl at 5 minutes). These results indicate that some of the heat-treated factor VIII concentrates contain the high-molecular-weight vWf multimers and may provide a safer, yet still effective, treatment for platelet-type vWd, and possibly for various types of vWd as well.
APA, Harvard, Vancouver, ISO, and other styles
3

Caulk, Alexander W., and Rudolph L. Gleason. "Treatment With Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Leads to Increase of Carotid Intima-Media Thickness in Mice." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14744.

Full text
Abstract:
Since the advent of highly active antiretroviral therapy (HAART), patients infected with human immunodeficiency virus-1 (HIV-1) are living longer lives. However, HIV-1-positive (HIV-1+) patients are now experiencing many non-AIDS related comorbidities including myocardial infarction, atherosclerotic lesions, and other preclinical markers of atherosclerosis including increased carotid intima-media thickness (cIMT), arterial stiffness, and impaired flow-mediated dilation (FMD). Studies have implicated the virus, the treatment, or both in the progression of these co-morbidities, causing the exact mechanisms of cardiovascular disease progression to remain unclear.
APA, Harvard, Vancouver, ISO, and other styles
4

Hansen, Laura, Manu Platt, Roy L. Sutliff, and Rudolph L. Gleason. "The Mechanical and Structural Effects of HIV Proteins on Murine Carotid Arteries." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53693.

Full text
Abstract:
Acquired immunodeficiency syndrome (AIDS) is considered a global epidemic with over 65 million people worldwide infected with the HIV-1 virus, the causative agent [1]. The development of highly active antiretroviral therapy (HAART) has significantly increased the life expectancy of people infected with the virus by slowing the progression to the development of AIDS. However, the treatment has also led to the emergence of early onset cardiovascular complications including myocardial infarction [2] and atherosclerotic lesions [3], as well as subclinical markers of atherosclerosis including increased carotid artery intima-media thickness [4], increased arterial stiffness [5–6], and endothelial dysfunction [6]. It appears that HAART and HIV-1-infection are independent risk factors for the development of atherosclerosis in adults [7]; however, the mechanism of disease progression remains unclear. There is a pressing need to identify mechanisms of early on-set cardiovascular disease associated with HIV-1 infection and HAART and to identify therapeutic strategies to reduce cardiovascular disease in HIV patients. The overall goal of this study is to test the hypothesis that over-expression of HIV proteins will lead to alterations in the biomechanical properties of large arteries.
APA, Harvard, Vancouver, ISO, and other styles
5

Tareq HAMMOODI, Zeyad. "CORONA EPIDEMIC (COVD 19) BETWEEN SHARIA AND MEDICINE." In International Research Congress of Contemporary Studies in Social Sciences (Rimar Congress 2). Rimar Academy, 2021. http://dx.doi.org/10.47832/rimarcongress2-7.

Full text
Abstract:
The Corona epidemic is a wide group of viruses that include viruses that can cause a group of illnesses in humans, ranging from the common cold to severe acute respiratory syndrome, as there is no definitive and specific treatment for the epidemic. The medicines used are helpful and supportive, and they mostly aim to reduce the patient’s temperature with the use of pulmonary resuscitation devices, as the body’s resistance depends on autoimmunity, as it is the main factor in preventing this epidemic, and here we must know the role of medical and forensic scholars in preventing and treating With what appears from this epidemic and other epidemics, we do not know when and how they will appear to the world. The emergence of this disease is an extension of several diseases before it and the so-called (contemporary diseases), which are contagious communicable diseases, including bird flonza disease, swine flonza, sass and AIDS, mad cow disease, Ebola, human papillomavirus, herpes simplex virus, yellow fever, and many others These diseases are epidemic.
APA, Harvard, Vancouver, ISO, and other styles
6

Borges, Érico Induzzi, André Lopez Fernandez, Louis Fernando Marques de Almeida, Juline do Prado Paes, Jandey da Glória Bigonha, Antônio José da Rocha, Herval Soares Ribeiro Neto, and Sônia Maria Cesar de Azevedo Silva. "Progressive Multifocal Leukoencephalopathy following Daratumumab therapy for refractory Multiple Myeloma – a case report." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.441.

Full text
Abstract:
Context: PML is a dymyeliniating disease of the brain, caused by JC virus infection reactivation in immunocompromised patients, especially by AIDS, hematological disease and immunosuppressive therapies. Case report: A 67-year-old woman was diagnosed with multiple myeloma (MM) in 2018 and use of bortezomib/cyclophosphamide/dexamethasone and thalidomide was ineffective. She underwent treatment with monthly daratumumab starting in January 2020. After one year, she experienced progressive amnesia, apathy and confusion. At admission, examination revealed apathy, monosyllabic communication and frontal release, progressing to mutism and abulia. T2 FLAIR-weighted MRI of the brain performed in March 2021 showed a hyperintense non-enhancing lesion affecting thalamus, internal capsule, lentiform and deep white matter of left lobes. MRI performed one month before symptoms onset showed a small lesion in subinsular region – indicating incipient involvement. Cerebrospinal fluid PCR was positive for JC viruses, and PML was diagnosed. Conclusions: This report proves that concomitant hematologic and drug- immunocompromised patients presenting with neurological symptoms should be investigated for PML. There are few reports in the literature of PML occurring in MM, especially after use of daratumumab, an anti-CD38 monoclonal antibody. Recently, one small case series demonstrated some improvement in pembrolizumab (a checkpoint inhibitor)-treated PML, but no routinely therapy is recommended. Understanding severity of both disease, patient was discharged receiving conservative treatment.
APA, Harvard, Vancouver, ISO, and other styles
7

Hyun, Sinjae, Sun Jin Moon, and Chong S. Kim. "Computational Modeling of Aerosol Deposition Characteristics in Cyclic Bifurcating Tube Flow." In ASME 2010 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2010. http://dx.doi.org/10.1115/sbc2010-19169.

Full text
Abstract:
An accurate model of the human respiratory system allows health scientists to gain insight into the interactions between particulate matter (PM) and the exposed surfaces of the lung airways. Respiratory dose simulations and modeling are frequently used for evaluating health effects of inhaled toxic substances [1–4] and for analyzing the risk potentials of inhaled toxic or harmful PM such as vehicle emissions [4,5]. Pharmaceutical companies and pulmonologists find it useful in evaluating efficacy of inhaled medicinal aerosols and devising new patient treatment regimen [6–8], especially in vulnerable population groups such as children, industrial workers, and the elderly [10]. Recently, the respiratory system has seen increased attention as a possible venue for drug delivery to fight diseases such as AIDS, diabetes, and various cancers, among others. Computational fluid dynamics modeling and simulation continues to be an important tool for understanding of delivery of pharmaceutical aerosols to the lung airways and thereby improving treatment of airway disease, particularly, asthma with bronchodilators and corticosteroids inhalers [11,12].
APA, Harvard, Vancouver, ISO, and other styles
8

Hanks, Bradley W., Mary Frecker, and Matthew Moyer. "Design of a Compliant Endoscopic Ultrasound-Guided Radiofrequency Ablation Probe." In ASME 2016 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/detc2016-59923.

Full text
Abstract:
Pancreatic cancer is one of the most deadly forms of cancer in the United States. Due to its late diagnosis, only 20% of patients diagnosed with the disease are eligible for surgical resection which is considered the preferred method of treatment. Radiofrequency ablation is a common cancer treatment modality for patients ineligible for open surgery. There is a lack of ablation probes which may be used to generate spherical heating zones which closely match the geometry of typical tumors. In particular, there are no endoscopic ablation probes commercially available in the United States. In this paper the design of a compliant endoscopic radiofrequency ablation probe is presented. This probe features an array of compliant tines which deploy through the cancerous tissue to effectively broaden the ablation zone. A thermal ablation model is used to inform the design of the geometry of the probe. In addition, finite element analysis is used to determine the feasibility of the compliant structures. These design tools are used as aids to inform the design and direct modifications toward a feasible probe which generates a spherical ablation zone.
APA, Harvard, Vancouver, ISO, and other styles
9

Silva, Joao Paste, Catarina Secundino, Tiago Timotio, and Aurea Angelica Paste. "Case report: Medullary cryptococcosis in a immunocompetent patient." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.619.

Full text
Abstract:
Context: Cryptococcosis is an important fungal infection that, after AIDS development globally, became more common, being an important cause of opportunistic infections. The pathogen normally gets in through the lungs, causes pulmonary infection and then spreads to another systems, particularly the nervous system in most cases. Along the clinical manifestation there was headache, fever, cranial neuropathies, altered mentation, lethargy, memory loss, and signals of meningeal irritation. Case-Report: A 48-year-old male patient with a one-year story of paraparesis in both legs, associated with pain, paresthesia, and progressive worsening to complete walking incapability, seeks medical consultation. Cerebrospinal fluid was turbid appearance, yellow colored, presence of RBC (1.239 cel/mm³) and leukocytes (149 cel/mm³ - 5% neutrophils, 91% lymphocytes and 4% monocytes), glucose of 23 mg/dL, chlorine of 96 mmol/L, and Cryptococcus neoformans was isolated. Immunosuppressive disease wasn´t found. In MRI, there were nodular images in the intradural and extradural sites through T11-T12 levels, compressing the spinal cord. Local biopsy revealed chronic granulomatous inflammatory process, consistent with the cryptococcosis suspect. Conclusions: The case represents an unusual manifestation of cryptococcosis, with an uncommon topography and profile, once it´s manifestation medullary and in a healthy individual is rare. The main differential diagnosis was spinal tuberculosis, an also rare disease yet with similar symptoms and relevant local epidemiology. To reach the diagnosis, laboratory study was necessary. The treatment was the same of cryptococcosis in general.
APA, Harvard, Vancouver, ISO, and other styles
10

Pangerti, Fitria Diyah Ayu, Pawito Pawito, and Hanung Prasetya. "Factors Affecting Adherence to Antiretroviral Therapy: Application of Theory of Planned Behavior in Malang, East Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.53.

Full text
Abstract:
Background: Adherence to antiretroviral (ARV) treatment is known as an important component in achieving the success of an optimal HIV therapy program. Poor adherence to antiretroviral therapy (ART) is associated with less effective viral suppression, which creating permanent treatment resistance. The purpose of this study was to examine factors affecting adherence to ARV therapy. Subjects and Method: A cross-sectional study was conducted in Malang, East Java, from September to October 2019. A sample of 200 PLWH was selected by fixed disease sampling. The dependent variable was adherence to ARV therapy. The independent variables were cues to action, perceived susceptibility, perceived benefit, attitude, and CST service. The data were collected by medical record and questionnaire. The data were analyzed by a multiple linear regression. Results: Adherence to ARV therapy in PLWH increased with strong cues to action (OR= 6.40; 95% CI= 3.13 to 13.12; p<0.001), strong perceived susceptibility (OR= 3.61; 95% CI= 1.82 to 7.13; p<0.001), strong perceived benefit (OR= 4.68; 95% CI= 2.37 to 9.28; p<0.001), and positive attitude (OR= 5.39; 95% CI= 2.69 to 10.83; p<0.001). CST service was associated with adherence to ARV therapy but it was statistically non-significant (OR= 0.63; 95% CI= 0.33 to 1.20; p=0.130). Conclusion: Adherence to ARV therapy in PLWH increases with strong cues to action, strong perceived susceptibility, strong perceived benefit, and positive attitude. CST Keywords: Care, support, and treatment service, people living with HIV/AIDS Correspondence: Fitria Diyah Ayu Pangerti. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java, Indonesia. Email: ayupangerti13@yahoo.com. Mobile: 081332600710. DOI: https://doi.org/10.26911/the7thicph.02.53
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "AIDS (Disease) Treatment Victoria"

1

van Dam, Johannes, and Sherry Hutchinson. Access to treatment for HIV/AIDS: Report of a meeting of international experts. Population Council, 2002. http://dx.doi.org/10.31899/hiv2002.1000.

Full text
Abstract:
As of December 2001, the number of people living with HIV/AIDS is estimated at 40 million, and most live in the developing world. Advances in the development and availability of antiretroviral (ARV) drugs have led to a paradigm shift in most of the industrialized world, where highly active ARV therapy has resulted in a significant reduction in the prevalence of AIDS-related morbidity and mortality. In most of the developing world, however, the focus of national programs and international support continues to be on prevention and care in the absence of ARV treatment. While the moral imperative to provide the best possible treatment for people with AIDS-related disease is widely recognized, national governments and donors have been reluctant to enter into this endeavor citing numerous concerns. Ministries of health and the international donor community need guidance on developing and implementing effective HIV/AIDS treatment programs. To explore and prioritize operations research questions about access to treatment for HIV/AIDS, the Horizons Program convened a two-day meeting of international researchers and program managers in Washington, DC, on June 12–13, 2001. This report presents the findings and recommendations discussed at the meeting.
APA, Harvard, Vancouver, ISO, and other styles
2

Zheng, Ruo-xiang, Xun Li, Jing Li, Zhen-wei Liu, Feng Jiang, Nicola Robinson, and Jian-ping Liu. Does Chinese herbal remedy Tangcao tablet work for the treatment of HIV/AIDS：a systematic review of controlled clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0042.

Full text
Abstract:
Review question / Objective: This study aims to evaluate the effectiveness and safety of Tangcao tablet (Tangcao) for treating people with HIV/AIDS. Condition being studied: Acquired immunodeficiency syndrome (AIDS) is a chronic infectious disease characterized by severe immunodeficiency caused by the human immunodeficiency virus (HIV). The infection attacks specifically the white blood cells, CD4+T (CD4) cells, weakening the immunity of individuals against infections such as tuberculosis. Without treatment, patients with AIDS may survive up to 2 years. Pneumocystis pneumonia and infections of the central nervous system are two of the most common causes of death in people with AIDS. AIDS still remains a significant global public health problem, with an estimated 37.7 million people infected with HIV at the end of 2020.
APA, Harvard, Vancouver, ISO, and other styles
3

Haider, Huma. Malaria, HIV and TB in Nigeria: Epidemiology and Disease Control Challenges. Institute of Development Studies (IDS), December 2021. http://dx.doi.org/10.19088/k4d.2022.040.

Full text
Abstract:
Nigeria has the world’s highest number of people affected by malaria and the world’s second largest human immunodeficiency virus (HIV)/AIDS burden. There is a high occurrence of co-infection of malaria in HIV patients (Gumel et al., 2021). Nigeria is also ranked as one of the thirty high tuberculosis (TB) and TB-HIV co-infection burden countries in the world (Odume et al., 2020, 8). Co-infection can make each disease more severe and potentially more infectious (Gumel et al., 2021; Jemikalajah et al., 2021; Chukwuocha et al., 2019). This rapid literature review highlights key aspects of the epidemiology of malaria, HIV and TB in Nigeria, in addition to challenges in controlling the three diseases, in terms of prevention, detection and treatment. This is part of a series of reports looking into Epidemiology of Malaria, human immune deficiency virus (HIV) and tuberculosis (TB) across a set of African Nations.
APA, Harvard, Vancouver, ISO, and other styles
4

Liang, BiYan, BiYan Liang, and Jian Wang. A Meta Analysis of the Efficacy of Tonic Method in Traditional Chinese Medicine for AIDS Immunological Nonresponses. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0077.

Full text
Abstract:
Review question / Objective: To evaluate the efficacy of tonic method in treating AIDS immunological nonresponses. Eligibility criteria: ①Study type: RCT based on tonic method in TCM for AIDS INRs. The language was limited to Chinese and English. ②The research object: HIV/AIDS patients with any disease stage; the intervention objects were adults with no gender restrictions. ③Intervention measures: The treatment group was treated with tonic prescriptions combined with ART, including four types of prescriptions for nourishing qi, nourishing blood, nourishing yin, or nourishing yang; the dosage, frequency, and method were not limited. The control group was treated with ART or mock agent and placebo. ④Outcome indicators: The observation indicators reported in the included studies should include at least one of the following indicators: 1) Effective rate of immune function reconstruction: formulated in accordance with "AIDS (Adult) Chinese Medicine Diagnosis and Treatment Program" (2016 Edition) , effective: CD4 + T lymphocyte counts increased by ≥ 50 cells/l or ≥ 30%, invalid: CD4+ T lymphocyte counts decreased by ≥ 50 cells/l or ≥ 30%; total effective rate = effective number/total number; 2) CD4+T lymphocyte counts level.
APA, Harvard, Vancouver, ISO, and other styles
5

Dual protection in an integrated community-based program: A case study of Tanzania Family Health/Ministry of Health Project in Mbeya. Population Council, 1998. http://dx.doi.org/10.31899/rh1998.1020.

Full text
Abstract:
One of the most pressing challenges for health programs in most sub-Saharan African countries is effectively addressing the increasing prevalence of HIV/AIDS. Recent evidence suggests that controlling sexually transmitted diseases (STDs) through undertaking preventive measures, early diagnosis, and treatment significantly slows the spread of HIV/AIDS. In regard to STI/HIV, Maternal and Child Health (MCH) and Family Planning (FP) clients are described as “low risk” groups. However, in a number of sub-Saharan African countries, the reported levels of STDs are significantly high enough to justify use of limited resources to target this group for STD services. MCH/FP programs have begun to get more involved in prevention of STDs/HIV among MCH and FP clients through providing integrated programs and integrated services. This move toward integration is gaining momentum, however it presents immense challenges for reproductive health (RH) programs in the region. The issue of the best cost-effective strategy to provide quality integrated MCH/FP/STD/HIV services in the context of scarce financial, laboratory, and technical resources is still unsettled, according to this report, including the technical challenge of altering existing MCH/FP services to simultaneously meet contraceptive and disease-control goals.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'AIDS (Disease) Treatment Victoria' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography